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Abstract 22 
Background. The use of veno-venous extracorporeal membrane oxygenation (vv-ECMO) is 23 
increasing in adults with severe respiratory failure. Observational data suggest that there 24 
are significant challenges to providing adequate nutritional support for patients on vv-25 
ECMO. We aimed to describe firstly the nutritional support practices in a large single-centre 26 
providing vv-ECMO to adults and secondly any association with clinical outcome. 27 
Methods. We conducted a retrospective review of patients receiving vv-ECMO on the 28 
Intensive Care Unit (ICU) of a large London teaching hospital. Adult patients admitted to the 29 
ICU with severe respiratory failure between December 2010 and December 2015 were 30 
included. Daily energy and protein delivery were compared with estimated targets and 31 
reasons for feeding interruptions were collected from electronic medical records. Adequate 32 
feeding was defined as 80-110% of estimated targets. 33 
Results. We analysed 203 eligible patients. Median duration of ICU stay was 21.0 (IQR, 34 
15.033.0) days and vv-ECMO 10.0 (IQR, 7.016.0) days. Although median energy (89.8% 35 
(IQR, 80.596.0%)) and protein (84.7% (IQR, 74.096.7%)) delivery was adequate, 36 
underfeeding of either energy or protein occurred on nearly third (28.3%) of nutrition 37 
support days. A higher admission severity of illness score was associated with inadequate 38 
protein delivery (p=0.040). Patients with more severe organ dysfunction on the first day of 39 
vv-ECMO received inadequate energy (p=0.026). The most common reasons for 40 
interrupted feeding were medical procedures (39.1%) followed by poor gastric motility 41 
(22.8%).  42 
Conclusion. Adequate energy and protein delivery during vv-ECMO is possible but 43 
underfeeding is still common, especially in those who are more severely ill or who have 44 
more severe organ dysfunction. Patients with inadequate energy or protein intake did not 45 
differ in ICU and 6-month survival. Prospective studies investigating optimal feeding in this 46 
patient cohort are required.  47 
  48 
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Introduction  49 
Veno-venous extracorporeal membrane oxygenation (vv-ECMO) is a temporary life support 50 
system that removes blood from the central venous circulation and returns oxygenated 51 
blood to the right atrium (1). The use of vv-ECMO in adults with severe respiratory failure is 52 
increasing, particularly since the H1N1 influenza pandemic of 2009 and 2010 (2, 3). The 53 
use of vv-ECMO has led to improved survival among patients with H1N1 (1-3), and 54 
importantly has been shown to do so without severe disability at six-months when 55 
compared with conventional management (4). However, the overal benefit of ECMO on 56 
mortality is inconclusive (5). 57 
In general, patients on the Intensive Care Unit (ICU) are commonly underfed, with 58 
data reporting around 50-70% of energy and protein targets are received (6-8). 59 
Observational studies demonstrate an association between underfeeding and worse 60 
outcomes, including mortality (9, 10). However, these results have not been confirmed in 61 
prospective randomised controlled trials (RCTs) over the first week of ICU admission (11-62 
13).  63 
Nutrition support is likely of great importance during vv-ECMO given these patients 64 
are some of the most severely ill, are more likely to have a prolonged stay on ICU and may 65 
have raised nutritional requirements due to increased protein catabolism secondary to 66 
inflammation and acute illness (14). However, despite the rapid increase in use of vv-67 
ECMO since 2010, there remains little information regarding optimal nutritional 68 
management of these patients. Guidelines on nutritional support in general critical illness 69 
recommend early (within 24–48 hrs) feeding using the enteral route as the first line (15-17). 70 
However, there are no specific nutritional guidelines during ECMO; the guidelines by 71 
Extracorporeal Life Support Organization simply mention that ‘full energy and protein 72 
support is essential’ (18).  73 
To our knowledge, only seven studies have been undertaken investigating nutrition 74 
support practices in patients receiving ECMO (19-25). Their findings indicate that despite 75 
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timely commencement of enteral nutrition, nutrition deficits are common (19, 20, 22, 24, 76 
25). However, there are important limitations in these studies; some do not report energy 77 
and protein intakes separately (19, 20), some data include veno-arterial ECMO (20, 22, 24, 78 
25), whilst other studies include non-ECMO days in their data analysis (24, 25).  79 
Gastrointestinal (GI) intolerances (26) are common causes of underfeeding in the 80 
general ICU population and this is also found in patients on ECMO with 50-73% of patients 81 
requiring ECMO receiving prokinetic medication (20, 23, 25), however whether this is a 82 
result of the severity of illness or due to an effect of ECMO itself is not known. 83 
Our aim was to describe nutritional practices in a single-centre providing vv-ECMO 84 
to assess the timing and adequacy of energy and protein delivery through gastric, jejunal 85 
and parenteral routes, GI complications during vv-ECMO therapy, and the difference in 86 
delivery of energy and protein during and after vv-ECMO. Further, we aimed to investigate 87 
the association of nutritional support adequacy with clinical outcome. 88 
 89 
Methods 90 
A retrospective observational study of patients receiving vv-ECMO was undertaken on our 91 
tertiary mixed medical and surgical intensive care unit which provides the ECMO referral 92 
service for 43 hospitals in South East England. The need for informed consent was waived 93 
and the study approved by our institutional review committee (reference number 2216).  94 
 95 
Inclusion and exclusion criteria 96 
Patients admitted to the ICU with severe respiratory failure requiring vv-ECMO between 97 
December 2010 and December 2015 were included if they were age ≥18 years at the time 98 
of admission and received ≥72 hours and no more than 6 months of vv-ECMO support. 99 
Patients were identified from a prospectively held database and patient records were 100 
searched from our electronic intensive care patient information system (ICIP, Philips, 101 
Netherlands). Patients were excluded if there was no documentation of calculated 102 
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nutritional targets or if they were able to eat and drink for the entire duration of ECMO 103 
support.  104 
 105 
Nutrition support protocol 106 
Patients on vv-ECMO commenced nutrition support according to the same protocol as 107 
general ICU patients which advocates commencing gastric feeding within 24–48 hours of 108 
admission, following which individualised nutritional targets were calculated by the ICU 109 
dietitian within 48-72 hours of admission. Energy targets were calculated using 25-30 110 
kcal/kg/day during vv-ECMO or during periods of no mechanical ventilation (27), and the 111 
Modified Penn State equation (28) was used during periods not on vv-ECMO, but still 112 
receiving mechanical ventilation. Protein requirements were calculated using a minimum of 113 
1.2 g/kg/day, with increases depending on clinical condition (e.g. continuous renal 114 
placement therapy). For patients with body mass index (BMI) ≥25 kg/m2, ideal body weight 115 
(IBW) and adjusted body weight (ABW) were used to calculate protein and energy 116 
requirements, respectively. 117 
Gastric residual volumes (GRVs) were assessed every four hours by nursing staff. 118 
Clinical guidelines recommended prokinetic therapy be considered after two GRV >300 ml, 119 
and then reducing the rate of feeding after three consecutive GRV >300 ml. If high GRV 120 
persisted for more than 72 hours, jejunal feeding (unless contraindicated) followed by 121 
parenteral nutrition (PN), was considered. Nasojejunal feeding tubes were placed by 122 
nursing staff or ICU dietitian at the bedside using an electromagnetic device (Cortrak, 123 
Halyard, UK). 124 
 125 
Data collection 126 
All data was retrospectively searched from our electronic patient records (IntelliVue Clinical 127 
Information Portfolio, ICIP, Release F.01.00, Philips Healthcare, USA). Age, weight, height 128 
and BMI were recorded at the time of admission to the ICU. Severity of critical illness was 129 
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calculated using APACHE II (Acute Physiology and Chronic Health Evaluation II) and 130 
recorded on the day of ICU admission (29) and the degree of organ failure was calculated 131 
using SOFA (Sepsis-related Organ Failure Assessment) and was recorded for the first day 132 
of both ICU admission and vv-ECMO therapy (30). Other data collected included gender, 133 
principal diagnosis and outcomes such as duration of vv-ECMO therapy, ICU stay, and ICU 134 
and six-month survival. 135 
The energy and protein delivered daily for each patient was collected for the days 136 
they were on vv-ECMO (always on the ICU) as well for the days following decannulation 137 
from vv-ECMO (data only recorded whilst on ICU). The first day of vv-ECMO and the day of 138 
vv-ECMO cessation were treated as the first and final day on vv-ECMO, respectively. Data 139 
were collected until both oral nutrition commenced and artificial feeding was either ceased, 140 
intentionally reduced to provide <100% requirements, or when a patient was discharged 141 
from ICU at our institution.  142 
Data on nutritional intake included energy and protein from EN, PN, intravenous (IV) 143 
glucose and propofol during a one day period (starting 06:00, finishing 05:59). Energy from 144 
propofol was included if it was running at a minimum rate of 10 ml/hr for six or more hours a 145 
day. 10% IV glucose was included in energy intake recording if the administered volume 146 
exceeded 1000 ml/day. 147 
Daily energy and protein delivery were compared with the estimated target that day. 148 
If targets were expressed as a range, the midpoint of the range was recorded.  For the first 149 
day on the ICU, nutritional targets were re-calculated as a proportion of a 24-hour period 150 
based on the time of admission, in order to ensure correct data representation. Similarly, on 151 
the patient’s last day on the ICU, nutritional targets were re-calculated as the proportion of a 152 
24-hour period based on the time of discharge or death.  153 
The overall energy and protein targets for periods on vv-ECMO and post vv-ECMO, 154 
were recorded as the mean of each period. The overall energy and protein delivery for 155 
these periods was also recorded as the mean of each period. 156 
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Adequate delivery of nutrition was defined as 80-110% of the target of energy or 157 
protein for that day, with underfeeding defined as <80% and overfeeding >110%. Although 158 
the optimal energy and protein intake in critical illness is much debated (31), recent studies 159 
have observed lower 60-day mortality when 80% of energy (32) and protein (8) targets 160 
were achieved. The upper limit of 110% was chosen to account for inaccuracies in 161 
estimated weight based targets. When analysing nutrition support days, patients who were 162 
underfed either energy or protein (e.g. underfed energy/ adequate protein and underfed 163 
energy/overfed protein) were categorised as underfed.  164 
The time taken to reach adequate energy and protein delivery over a 24-hour period 165 
was calculated from the time of admission to the first hour of the 24-hour period of 166 
adequate delivery.  167 
The main, second and third routes of feeding during vv-ECMO were recorded based 168 
on the length of time a patient relied on any one route. The longest duration of any one 169 
route was recorded as the main route. Special attention was paid to capture possible 170 
reasons for underfeeding. The number, duration and main reason for feeding interruptions 171 
during vv-ECMO were recorded. The main reason was defined as the reasons for the 172 
longest interruptions. If EN was stopped or reduced due to GRV >300 ml, three preceding 173 
values and name/dose of a prokinetic agent administered, were recorded.  174 
 175 
Statistical Analysis 176 
Data were analysed using SPSS, version 23 (IBM SPSS Software NY, USA). Categorical 177 
data are presented as n (%), continuous data as mean (standard deviation [SD]) for 178 
normally distributed data and median (interquartile range [IQR]) for non-normally distributed 179 
data. Assumptions for normality were assessed using Kolmogorov-Smirnov One-Sample 180 
test.  181 
Categorical data were compared between two groups using Chi-squared test. 182 
Continuous data, which was not normally distributed, were compared between two groups 183 
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using Mann-Whitney test and between three groups using Kruskal-Wallis test and 184 
Bonferroni post hoc correction. Nutritional delivery during vv-ECMO and post vv-ECMO 185 
were compared using the Wilcoxon Signed Ranked test or sign test (where distribution was 186 
asymmetrical on inspection of a histogram). P < 0.05 was considered statistically 187 
significant. 188 
 189 
Results 190 
241 patients received vv-ECMO between December 2010 and December 2015. Of the 241 191 
patient records assessed for eligibility, 38 were excluded (18 <72h on vv-ECMO, seven no 192 
estimated nutrition target, five <18 years of age, three received oral nutrition only, two had 193 
incomplete nutrition delivery data, one incorrect medical number, one with oral nutrition 194 
intake during vv-ECMO and supplementary or no artificial nutrition, and one > six months 195 
on vv-ECMO) resulting in 203 patient records included in this analysis. 196 
Two hundred and two patients were admitted for medical reasons and one was 197 
admitted for surgery. Details of the demographic and baseline data of all included patients 198 
are shown in Table 1. 199 
 200 
 201 
 202 
 203 
 204 
 205 
 206 
 207 
 208 
 209 
 210 
 211 
 212 
 213 
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Table 1. Demographic and baseline clinical data of 203 patients. 214 
Characteristics Result 
Age (year), median (IQR) 44.0 (33.055.0) 
Gender, n (%)  
   Female 91 (44.8) 
   Male 112 (55.2) 
Weight (kg), median (IQR) 80.0 (65.0100.0) 
BMI (kg/m
2
), median (IQR)* 27.0 (23.733.0) 
Principal diagnosis  
             Aspiration, n (%) 11 (5.4) 
             Asthma, n (%) 14 (6.9) 
Influenza, n (%) 35 (17.2) 
Pneumonia, n (%) 94 (45.3) 
Sepsis, n (%) 12 (5.9) 
Other infectious respiratory failure, n (%) 10 (4.9) 
Other respiratory failure, n (%) 29 (14.3) 
APACHE II score, median (IQR) 18 (1521) 
SOFA score on admission, median (IQR) 6 (411) 
SOFA score on first day of vv-ECMO, median (IQR) 7 (411) 
vv-ECMO duration (days), median (IQR) 10.0 (7.016.0) 
ICU duration (days), median (IQR) 21.0 (15.033.0) 
vv-ECMO survival, n (%) 172 (84.7) 
ICU survival, n (%) 163 (80.3) 
Six-month survival, n (%) 159 (78.3) 
Estimated energy requirements (kcal/day), median (IQR) 1800 (16002000) 
Estimated protein requirements (g/day), median (IQR) 87.0 (75.0100.0) 
*n=202; BMI for one patient unknown  
APACHE II: Acute Physiology and Chronic Health Evaluation II; BMI: Body Mass 
Index; ICU: Intensive Care Unit; SOFA: Sepsis-related Organ Failure 
Assessment; vv-ECMO: veno-venous extra corporeal membrane oxygenation.  
 215 
 216 
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Nutrient delivery and adequacy during vv-ECMO 217 
VV-ECMO support was provided on a total of 2989 days, which consisted of 2900 days of 218 
artificial nutritional support (EN, PN). During these nutritional support days on vv-ECMO the 219 
median energy delivered was 89.8% (IQR 80.596.0%) and protein 84.7% (IQR 220 
74.096.7%) of targets (Table 2). However, underfeeding still occurred in a large proportion 221 
of patients (Figure 1). Protein and/or energy intake was inadequate on approximately one 222 
quarter of days (Table 2). 223 
 224 
  225 
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Table 2. Energy and protein intake from nutritional support and adequacy during vv-ECMO of all 203 patients 226 
included in the study. 227 
 Outcomes 
Energy intake whilst on vv-ECMO  
Overall intake (% of target), median (IQR) 89.8 (80.596.0) 
Minimum – maximum (% of target) 37.0 -119.3 
Energy from IV glucose, median (minimum – maximum) (kcal/patient) 0.0 (0.0  3692.4) 
Energy from propofol, median (minimum – maximum) (kcal/patient) 0.0 (0.02290.9) 
Cumulative energy balance whilst on vv-ECMO
a
 (kcal), median (IQR) 1625.6 (4088.3 to 540.0) 
Protein intake whilst on vv-ECMO  
             Overall intake (% of target), median (IQR) 84.7 (74.096.7) 
Minimum – maximum (% of target) 25.9-133.8 
Cumulative protein balance whilst on vv-ECMO (g), median (IQR) 117.1 (222.9 to 22.1) 
  
Adequacy of energy intake, n (%) days
b 
 
 Underfeeding  694 (23.9) 
 Adequate feeding 1830 (63.1) 
 Overfeeding 376 (13.0) 
Adequacy of protein intake, n (%) days
b
  
 Underfeeding  790 (27.2) 
 Adequate feeding 1439 (49.6) 
 Overfeeding 671 (23.1) 
Adequacy of energy and protein intake, n (%) days
b
  
 Underfeeding either energy or protein 822 (28.3) 
 Adequate feeding both energy and protein 1203 (41.5) 
 Overfeeding either energy or protein 875 (30.2) 
a 
Balance calculated as the difference between estimated target
 
and delivery 228 
b
Total number of nutrition support days was 2900 229 
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 230 
A 231 
 232 
B 233 
Figure 1. A: Distribution of mean intakes of prescribed energy (A) and protein (B) per 234 
patient during vv-ECMO. Feeding was considered adequate if 80-110% of estimated 235 
targets were met (highlighted in dark grey).   236 
 237 
The median time taken to start nutritional support was 13.5 hours (IQR, 9.023.5) 238 
and 197 patients (96.6%) received nutrition support within 48 hours. The median time to 239 
reach adequate intake of both energy and protein over a 24-hour period was 68.8 hours 240 
(IQR, 41.5105.8), although 13 (6.4%) patients never achieved adequate intake. The 241 
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median time taken to reach adequate energy intake was 54.5 hours (IQR, 36.077.8) (five 242 
(2.5%) patients excluded due to never achieving adequate intake) and for protein was 59.5 243 
hours (IQR, 36.986.0) (11 (5.4%) patients excluded due to never achieving adequate 244 
intake).  245 
 246 
Route of feeding 247 
The most common route of feeding during vv-ECMO was gastric (123 patients, 60.6%) 248 
followed by jejunal (70 patients, 34.5%) and parenteral (10 patients, 4.9%). Jejunal feeding 249 
was attempted in another 20 (9.9%) patients but was unsuccessful as the clinician was not 250 
able to advance the tube post-pylorically and therefore, the gastric route was used. Two 251 
patients were admitted with a long-term EN feeding tube – one percutaneous endoscopic 252 
gastrostomy tube and the other percutaneous endoscopic jejunostomy tube. 253 
 254 
Nutritional adequacy and outcomes 255 
Patients whose median protein intake represented underfeeding (<80% requirements) 256 
(n=78) had higher APACHE II score on ICU admission than those with adequate (n=111) 257 
(p=0.040), and patients whose average energy intake represented underfeeding (n=48) had 258 
higher SOFA score on the first day of vv-ECMO than those with adequate (n=150) 259 
(p=0.026). Patients with inadequate energy or protein intake did not differ in the time taken 260 
to start nutritional support or ICU and 6-month survival (Table 3). However, those with 261 
adequate energy (p<0.001) and protein (p=0.001) delivery had longer duration of vv-ECMO 262 
than those without (Table 3). 263 
Table 3. Associations between outcomes and adequacy of energy and protein delivery during vv-ECMO.  264 
 
Energy
a
 
p value 
 
Protein
b
 p 
value 
 
Adequate  
(80110% of target)  
Underfeeding  
(<80% of target) 
Adequate  
(80110 % of target) 
Underfeeding  
(< 80 % of target) 
Number of patients, n (%) 150 (73.9) 48 (23.6)  111 (54.7) 78 (38.4)  
Disease severity scores, median (IQR)       
 APACHE II score 18.0 (15.020.0) 19.0 (15.022.8) 0.113
a
 18.0 (14.020.0) 19.0 (16.022.0) 0.040
c
 
 SOFA score on admission  5.5 (4.011.0) 8.0 (4.011.0) 0.117
a
 6.0 (4.011.0) 8.0 (4.012.0) 0.440
c
 
 SOFA score on first day of vv-ECMO 7.0 (4.011.0) 9.0 (5.012.0) 0.026
a
 7.0 (4.011.0) 8.5 (4.012.0) 0.201
c
 
vv-ECMO duration, median (IQR) 11.0 (8.018.0) 8.0 (6.010.0) <0.001
a
 11.0 (7.017.0) 8.0 (7.012.0) 0.001
c
 
ICU duration, median (IQR) 23.0 (15.036.8) 18.5 (11.338.8) 0.052
c
 21.0 (15.033.0) 20.5 (14.030.3) 0.304
c
 
Survival       
 Whilst on vv-ECMO, n (%) 124 (82.7) 43 (93.8) 0.129
c
 92 (82.9) 67 (85.9) 0.577
d
 
 Whilst on ICU, n (%) 119 (79.3) 39 (81.3) 0.773
c
 88 (79.3) 62 (79.5) 0.972
d
 
 At six-months, n (%) 116 (77.3) 38 (79.2) 0.790
c
 86 (77.5) 61 (78.2) 0.906
d 
a
 Five patients, who were overfed energy (>110% of target), were excluded from analysis due to low numbers 
b 
Eleven patients, who were overfed protein (>110% of target), were excluded from analysis due to low numbers 
c
 Mann-Whitney test
  
d
 Chi-squared test 
APACHE II: Acute Physiology and Chronic Health Evaluation II; ICU: Intensive Care Unit, IQR: interquartile range; SOFA: Sepsis-related Organ Failure Assessment; vv-
ECMO: veno-venous extra corporeal oxygenation 
Table 3. Continued.  265 
 
Energy 
p value 
 
Protein 
p value 
 
Adequate  
(80110% of target)  
Underfeeding  
(<80% of target) 
Adequate  
(80110 % of target) 
Underfeeding  
(< 80 % of target) 
Feeding started from ICU admission (hr), median (IQR) 13.5 (8.923.5) 15.5 (10.123.1) 0.506
a
 13.5 (8.524.0) 15.3 (10.523.5) 0.393
a
 
Time taken to reach adequate energy and protein 
intake over a 24-hr period (hr), median (IQR) 
69.5 (43.6105.0) 
e
 70.5 (41.3116.5) 
f
 0.492
a
 59.8 (38.197.4)
 g
 81.5 (50.6113.0) 
h
 0.022
a
 
a
 Mann-Whitney test
  
e 
Nine patients never reached the target. Number of patients 141. 
f
 Three patients were never underfed. Number of patients 45. 
g
 Seven patients never reached the target. Number of patients 104. 
h 
Four patients never underfed. Number of patients 74. 
APACHE II: Acute Physiology and Chronic Health Evaluation II; ICU: Intensive Care Unit, IQR: interquartile range; SOFA: Sepsis-related Organ Failure Assessment; vv-
ECMO: veno-venous extra corporeal oxygenation 
Interruptions to feeding 266 
Feeding interruptions occurred in 184 (90.6%) patients at least once and 95 (46.8%) 267 
patients had more than two interruptions. The median number of interruptions during vv-268 
ECMO was two (IQR, 14) and the median duration was 9 (IQR, 3.032.0) hours. The 269 
main reason for interruptions to feeding are shown in Table 4.  270 
 271 
Table 4. The frequency of the main reason for interrupting a feed during vv-ECMO.  272 
Main reason for feed interruption 
Number of patients (%) 
(total 184 patients) 
Procedures (bedside and operating room) 72 (39.1) 
GI intolerances 42 (22.8) 
Vomit 19 (10.3) 
Concerns over abdominal distention and constipation 12 (6.5) 
High gastric residual volume 10 (5.4) 
             High stool output 1 (0.5) 
No access or mechanical complications related to feeding
 a
 28 (15.2) 
Not documented 16 (8.7) 
Investigations 15 (8.2) 
GI bleed or blood in aspirate 5 (2.7) 
In anticipation of feeding tube extubation 4 (2.2) 
Other
b
 2 (1.1) 
a 
Mechanical complications such as unable to site feeding tube, feeding tube extubation, tube blockage  
b 
Other included hyperglcyaemia and propofol syndrome 
 
 273 
Prokinetic agents were used in 106 patients (52.2%). The most commonly used 274 
agent was metoclopramide which was used in 104 patients (51.2%). Erythromycin was 275 
used in 16 (7.9%) and domperidone was used in one patient (0.4%).   276 
 277 
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Nutrient adequacy during vv-ECMO vs post vv-ECMO 278 
Overall, 166 patients remained in our ICU post-ECMO. The median energy target for these 279 
patients during vv-ECMO was 1800 kcal/d (IQR, 16192024kcal/d) and after vv-ECMO 280 
decannulation was 1888 kcal/d (IQR, 16502100 kcal/d) (p<0.001). The median protein 281 
target during vv-ECMO was 88.8 g/day (IQR, 75.0100.0 g/d), and post-vv-ECMO 88.1 282 
g/day (IQR, 75.0100.0 g/d) (p=0.253).  283 
There was a small but statistically significant difference in the proportion of energy 284 
and protein delivery between the vv-ECMO and post vv-ECMO periods, with median 285 
energy delivery during vv-ECMO being 89.8% (IQR, 80.596.0%) and post vv-ECMO 286 
being 93.4% (IQR, 80.7101.0%)(p=0.05), and for protein the values were 84.7% (IQR, 287 
74.096.7%) and 91.2% (IQR, 74.0100.6%) (p=0.014), respectively. 288 
 289 
Discussion 290 
To our knowledge, this is the largest study investigating the provision of nutrition support in 291 
adults receiving vv-ECMO. Our results show that delivery of adequate energy and protein 292 
is possible, but underfeeding remains common. Further, we found that a higher APACHE II 293 
score on admission to our ICU was associated with lower protein delivery and a higher 294 
degree of organ failure on the first day of vv-ECMO with lower energy delivery.  295 
Previous observational studies have reported difficulty achieving nutritional targets 296 
in patients receiving ECMO due to frequent feeding interruptions (20, 25). In our cohort, 297 
we also report feeding interruptions to be frequent with over 90% of patients having their 298 
feed interrupted at least once and almost half having at least two interruptions, for a 299 
median duration of 9 hours. Similar to Ridley et al. (25) we found fasting for procedures 300 
and GI intolerances to be the main reasons for these interruptions. Despite this, we found 301 
the median delivery of energy to be 89.8% (IQR, 80.596.0%) and protein 84.7% (IQR, 302 
74.096.7%) which, according to our a priori definition, is considered adequate at the 303 
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population level. However, the finding that patients were underfed energy or protein on 304 
one in three days during their vv-ECMO highlights that energy and protein debt can still 305 
occur, especially following prolonged and repeated feeding interruptions.  306 
It is possible that our higher nutritional intakes compared with others are due to our 307 
higher usage of post-pyloric feeding tubes which we have previously reported to be 308 
successfully placed at the bedside using an electromagnetic device (33). Results may also 309 
have been influenced by changes to our feeding protocol during the period of this study; 310 
the protocol was updated to include a high protein enteral formula along with additional 311 
dietetic staffing on the ICU allowing ‘catch-up’ feeding to be prescribed on an individual 312 
basis as required.  313 
There was an association between relative underfeeding and reduced length of stay 314 
on ECMO. Our results are consistent with an Australian ECMO cohort (24) where 315 
increased delivery of energy and protein was associated with longer vv-ECMO support. In 316 
addition, we also found the same was true for increased delivery of energy, but not protein 317 
and ICU length of stay. The reasons for this are unclear, but one contributing factor may 318 
be that the patients who receive vv-ECMO for longer spend a smaller proportion of time 319 
achieving a target feeding rate than those who receive vv-ECMO for a shorter time (we did 320 
not adjust for duration of vv-ECMO when calculating delivery). Patients may also become 321 
more medically stable and require fewer procedures and investigations the longer they 322 
receive on vv-ECMO, thus allowing higher nutritional intake.  323 
There was an association between increased severity of illness and adequacy of 324 
nutrition, with statistically significantly higher SOFA and APACHE II scores, in the underfed 325 
group. Although clearly retrospective observational data is not a demonstration of 326 
causality, it is clinically plausible that increased severity of illness results in increased 327 
gastric stasis and increased requirement for procedures to be performed.  328 
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We found an association between higher APACHE II and SOFA scores and 329 
inadequate delivery of protein and energy, respectively. The nutrition risk of these patients 330 
should not be discounted. A first glance at the variables contributing to a score such as 331 
NUTRIC (age, APACHE II and SOFA) (39, 40) may lead the clinician to classify patients in 332 
our cohort as low risk. However, given that the patients in the current study have a 333 
prolonged stay both on ECMO and in the ICU, not counting the days in ICU prior to 334 
retrieval for ECMO from referring centres, we feel these patients should be classified as 335 
high nutrition risk and steps taken to enhance the delivery of nutrition support from ECMO 336 
commencement. In addition, nutrition risk only determines mortality, with the effect on 337 
muscle wasting and functional outcomes in ICU, on the whole, is currently unknown. 338 
We did not find an association between the adequacy of energy and protein 339 
delivery, and either ICU or six-month mortality. This is in contrast to others where an 340 
association between improved energy and protein delivery (≥80% of targets) and lower 341 
ICU mortality was found for patients on veno-arterial ECMO (27). This may reflect either 342 
differences in the severity of illness or the underlying illness (cardiogenic shock compared 343 
with acute respiratory distress syndrome) between patients receiving veno-arterial and vv-344 
ECMO.  345 
As previously reported in observational studies of ECMO patients, we found GI 346 
intolerances to be a common contributor to feeding interruptions. This was mainly 347 
incidence of vomiting and concerns regarding abdominal distention and GI dysmotility 348 
which may be a reflection of poor gut perfusion which has been mentioned by others (24).  349 
We found a small, but statistically significant improvement in the delivery of energy 350 
and protein in the patients who remained on our ICU post-ECMO, when compared with 351 
their stay on ECMO which has been previously reported by others (20). These results may 352 
reflect gradual recovery from critical illness and therefore improved GI function and less 353 
requirement for procedures, rather than a result of no longer being on vv-ECMO per se.  354 
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 355 
Limitations 356 
The current study has the limitations of being a single-centre, retrospective study. In 357 
addition, because nutritional targets for the first day were re-calculated as a proportion of a 358 
24-hour period based on the time of admission, the first day on vv-ECMO was not always 359 
representing one whole day. Therefore, the adequacy of feeding expressed as a number 360 
of days, may have been overestimated in some cases. Similarly, requirements for both 361 
energy and protein are estimated using calculations and usually based on an estimated or 362 
previous weight which may influence the results. It is possible that by using a weight-363 
based equation, we have significantly over or underestimated energy targets. Two 364 
methods to measure energy expenditure using indirect calorimetry in this population have 365 
been described (34, 35), and feeding to measured, rather than calculated, requirements 366 
may be one approach to limiting underfeeding or overfeeding in the future. In addition, the 367 
protein targets calculated for patients in this study are lower than those recently 368 
recommended in the American Society for Parenteral and Enteral Nutrition guidelines. 369 
Although the evidence for this recommendation is weak (17), it is entirely plausible that 370 
providing higher protein targets for  these patients may have resulted in higher protein 371 
delivery and improved outcome. Lastly, we have defined adequate energy and protein 372 
targets based on currently available evidence for the general critically ill population, but the 373 
overall optimal feeding strategy for critically ill patients remains under debate.  374 
 375 
Conclusion 376 
Adequate energy and protein intake is possible in patients receiving vv-ECMO support but 377 
underfeeding is still common especially in those patients who are more severely ill or have 378 
more severe organ dysfunction. As on the ICU in general, not all patients requiring vv-379 
ECMO are the same, underscoring the need for focused research in this area. Studies 380 
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investigating the impact of underfeeding on outcomes such as complications and mortality 381 
during vv-ECMO could help us to understand the nutritional needs of this patient group. 382 
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